Paris, France

Leda Mannent

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Leda Mannent: Innovator in Therapeutic Methods

Introduction

Leda Mannent is a prominent inventor based in Paris, France. She has made significant contributions to the field of medicine, particularly in the development of therapeutic methods for various conditions. With a total of four patents to her name, her work has the potential to impact many lives.

Latest Patents

Mannent's latest patents include innovative methods for treating chronic sinusitis with nasal polyps. This invention provides methods for decreasing a nasal polyp score in a subject by administering a therapeutic composition that includes an interleukin-4 receptor (IL-4R) antagonist. Another notable patent focuses on treating active eosinophilic esophagitis. This invention outlines methods for treating, preventing, or reducing the severity of this condition by administering a therapeutic composition that comprises an IL-4/IL-13 pathway inhibitor.

Career Highlights

Throughout her career, Leda Mannent has worked with leading companies in the biotechnology sector, including Sanofi Biotechnology and Regeneron Pharmaceuticals. Her experience in these organizations has allowed her to develop and refine her innovative ideas.

Collaborations

Mannent has collaborated with notable professionals in her field, including Allen Radin and Gianluca Pirozzi. These partnerships have contributed to her success and the advancement of her inventions.

Conclusion

Leda Mannent is a trailblazer in the field of therapeutic innovations, with a focus on addressing significant medical challenges. Her patents reflect her dedication to improving patient outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…